MLM Ranks

USANA Revenue Drops 7% to $855 Million in 2024

USANA Health Sciences Reports Fiscal Year 2024 Financial Results

Financial Overview

USANA Health Sciences, Inc. (NYSE: USNA) announced its financial results for the fourth quarter and fiscal year ended December 28, 2024. The company also finalized the acquisition of a 78.8% controlling ownership stake in Hiya Health Products, LLC on December 23, 2024. As a result, Hiya’s financial contribution to USANA’s fourth quarter and annual results was minimal.

Given the acquisition, the company now includes Adjusted diluted EPS(1) and Adjusted EBITDA(2) as key financial metrics. Net earnings, diluted EPS, and adjusted financial figures in this release represent amounts attributable to USANA.

Key Financial Results

Fourth Quarter 2024 vs. Fourth Quarter 2023

  • Net sales: $214 million (vs. $221 million)

  • Net earnings: $4.5 million (vs. $16.8 million)

  • Diluted EPS: $0.23 (vs. $0.87)

  • Adjusted diluted EPS(1): $0.64 (vs. $0.87)

  • Adjusted EBITDA(2): $25 million (vs. $32 million)

  • USANA Active Customers: 454,000 (vs. 483,000)

Jim Brown, CEO of USANA, smiling on stage in a professional suit and tie.USANA Revenue Growth Q1

Fiscal Year 2024 vs. Fiscal Year 2023

  • Net sales: $855 million (vs. $921 million)

  • Net earnings: $42.0 million (vs. $63.8 million)

  • Diluted EPS: $2.19 (vs. $3.30)

  • Adjusted diluted EPS(1): $2.59 (vs. $3.30)

  • Adjusted EBITDA(2): $110 million (vs. $128 million)

Fiscal Year 2025 Outlook

  • Consolidated net sales: $920 million – $1.0 billion (8% – 17% growth)

  • Net earnings: $29 million – $41 million

  • Diluted EPS: $1.50 – $2.20

  • Adjusted Diluted EPS(1): $2.35 – $3.00

  • Adjusted EBITDA(2): $107 million – $123 million

CEO Commentary

Jim Brown, President and CEO of USANA, commented:

“USANA delivered fourth quarter results above our internal expectations, highlighted by 7% sequential net sales growth. The Americas & Europe region showed year-over-year and sequential sales growth, while the Asia Pacific region performed in line with expectations. Additionally, we generated strong cash flow during the quarter, maintaining a healthy net cash position. As we move into 2025, we are confident in our ability to build on this performance.”

About USANA

For over 30 years, USANA Health Sciences (NYSE: USNA) has provided premium nutritional and lifestyle products. With a commitment to scientific research and innovation, USANA offers a range of award-winning supplements, Celavive skincare, and Active Nutrition lines.

As a trusted brand in the health and wellness industry, USANA continues to empower individuals to lead healthier lives through high-quality products and science-backed solutions.

Discover more at USANA.com or visit whatsupUSANA.com for company updates.

Reviews:

There are no reviews yet. Be the first one to write one.

Leave Your Review Here: